Walther Wever appointed new chairman of the CURANUM AG management board

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro   adhoc with the aim of a Europe-wide distribution. The issuer is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Company Information/New chairman of the CURANUM AG


Ad hoc announcement

Walther Wever appointed new chairman of the CURANUM AG management board

In its meeting today, the supervisory board of CURANUM AG, Munich, has appointed Mr. Walther Wever (54) as management board member and chairman of the management board (CEO), effective as from October 1, 2010. Following the dismissal of Mr. Bernd Rothe on September 3, 2010, Mr. Wever will hold this position on an interim basis up to June 30, 2011. Walther Wever was previously active as CFO of VARTA AG and held the position of management board chairman of VARTA Automotive AG up to 2009. His main areas of responsibility at Curanum include corporate development and strategy, mergers and acquisitions as well as investor relations. With the appointment of Mr. Walther Wever as CEO, the Curanum AG management board comprises three members again, with Ms. Judith Barth active as CFO and Ms. Sabine Merazzi-Weirich holding the position of COO.

Munich, September 28, 2010

The management board

@@start.t2@@end of announcement                                                 euro adhoc

ots Originaltext: Curanum AG
Im Internet recherchierbar:

Further inquiry note:
Bettina Pöschl
Tel. +49(0)89-242065-69

Branche: Healthcare Providers
ISIN:      DE0005240709
WKN:        524070
Index:    CDAX, Classic All Share, Prime All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              München / regulated dealing

Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: